In addition, NAT10 is highly overexpressed in multiple tumor types, including melanoma, and overexpression of NAT10 correlates with worse outcomes in patients with hepatocellular carcinoma [6,7]. The gene discussed is NAT10; the disease is hepatocellular carcinoma.